Teva rolls out generic Nexavar tablets
Sorafenib tablets are used to treat a type of liver cancer called hepatocellular carcinoma, which cannot be removed by surgery.
Teva is introducing a new generic product — sorafenib tablets.
The generic of Nexavar tablets is a prescription medication used to treat a type of liver cancer called hepatocellular carcinoma, which cannot be removed by surgery.
[Read more: Amneal touts 26 generic new product launches in 2022]
In addition, the tablets are also used to treat a type of kidney cancer called renal cell carcinoma; and a type of thyroid carcinoma that can no longer be treated with radioactive iodine and is progressing, the company said.